Joshua Schulman, M.D.
Clinical Professor
To see if Joshua Schulman is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
VA Northern CA Health Care System
Sacramento VA Medical Center
10535 Hospital Way
Mather, CA 95655
Phone: 916-843-7000
Philosophy of Care
Dr. Schulman brings a rigorous, patient-centered approach to the diagnosis and management of skin disease. He is dedicated to serving and advancing the needs of our veteran population.
Clinical Interests
Dr. Schulman is a board-certified dermatologist and dermatopathologist who provides both expert clinical care and interpretation of skin biopsy specimens. He is the Director of Dermatopathology and the Assistant Chief of Dermatology for the VA Northern California Health Care System.
Research/Academic Interests
Dr. Schulman has published extensively about the pathology of neoplastic and inflammatory skin disease, and he has received multiple awards as a passionate clinician-educator.
Undergraduate School
B.A., Princeton University, 2004
Medical School
M.D., Harvard Medical School, 2009
Internship
Pediatrics, Massachusetts General Hospital, 2009-2010
Residency
Dermatology, University of California, San Francisco, 2010-2013
Fellowship
Research Fellowship, Howard Hughes Medical Institute, 2008
Fellowship
Dermatopathology, University of California, San Francisco, 2013-2015
Volunteer Faculty Teacher of the Year, UC Davis Department of Dermatology, 2017, 2021,
Volunteer Faculty Teacher of the Year, UC Davis Department of Pathology and Laboratory Medicine, 2016, 2021,
1. Zhang WR, Bhutani T, Schulman JM, North JP. “The association of interleukin-36 staining intensity with histopathologic findings of eosinophil count and spongiosis in patients with psoriasis: A secondary analysis of a retrospective immunohistochemical and chart review pilot study.” J Cutan Pathol. 2025; 52(4):251-3. doi: 10.1111/cup.14711; PMID 39215601
2. Smith MP and Schulman JM. “Emerging applications of artificial intelligence in dermatopathology.” Current Dermatol Reports. 2024; doi:10.1007/s13671-024-00431-1.
3. Mitra A and Schulman J. “Expression of Ber-EP4 and CD34 can distinguish clear-cell basal cell carcinoma from trichilemmoma: a case series.” Indian J Dermatol Venereol Leprol 2023;doi:10.25259
4. Shawa H, Dahle S, Schulman JM. “Compound clear cell sarcoma: case report with ulceration and pagetoid scatter.” Am J Dermatopathol. 2022;44(9):687-90.
5. Beroukhim K, Wang JZ, Schulman JM, Levin E, Liao W, Danesh MJ. “Examination of tar-induced verrucous growths reveals absence of human papillomavirus.” Am J Dermatopathol. 2019;41(11):865-7.
6. Schulman JM, Pauli ML, Neuhaus IM, Sanchez Rodriguez R, Taravati K, Shin US, McCalmont TH, and Rosenblum MD. “The distribution of cutaneous metastases correlates with local immunologic milieu.” J Am Acad Dermatol. 2016;74(3):470-6.
7. Schulman JM, Oh DH, Sanborn JZ, Pincus L, McCalmont TH, and Cho RJ. “Multiple hereditary infundibulocystic basal cell carcinoma syndrome associated with a germline SUFU mutation.” JAMA Dermatol. 2016;152(3):323-7.